GSK and CureVac sign £132m deal to develop multi-variant Covid vaccine

GlaxoSmithKline and Germany’s CureVac have reached a €150m (£132m) settlement to develop a subsequent era of Covid-19 vaccines focusing on

Read more

Sputnik V vaccine has 91.6% efficacy against symptomatic Covid, Russian trial suggests

Russia’s Sputnik V vaccine has 91.6% efficacy against symptomatic coronavirus, interim trial outcomes have prompt. The preliminary findings are primarily

Read more

AstraZeneca denies pulling out of talks as EU Covid vaccine row deepens

A row over coronavirus vaccine shortages within the EU has descended into farce as AstraZeneca denied claims by the European

Read more

Germany challenges AstraZeneca Covid vaccine efficacy reports

The German authorities has challenged reports of a lower-than-expected efficacy price of the Oxford/AstraZeneca vaccine for older folks, whereas reiterating

Read more

French self-esteem hit after Pasteur Institute abandons Covid vaccine

French politicians have reacted with dismay to information that the celebrated Pasteur Institute is abandoning its essential coronavirus vaccine after

Read more